Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fekkar

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Clinical Microbiology|September 12, 2014
PCR-based detection of Toxoplasma gondii DNA in blood and ocular samples for diagnosis of ocular toxoplasmosisC Bourdin, A Busse, E Kouamou, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant <i>Aspergillus</i> Section <i>Fumigati</i> Clinical IsolatesS Dellière, L Verdurme, J Bigot, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2013
Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofunginA Fekkar, I Meyer, J Y Brossas, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 23, 2016
Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and nonneutropenic patientsS Imbert, L Gauthier, I Joly, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 4, 2016
Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemiaS Imbert, L Castain, A Pons, et al.
Journal of Clinical Microbiology|January 21, 2011
Direct genotyping of Toxoplasma gondii in ocular fluid samples from 20 patients with ocular toxoplasmosis: predominance of type II in FranceA Fekkar, D Ajzenberg, B Bodaghi, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2020
Species Distribution and Comparison between EUCAST and Gradient Concentration Strips Methods for Antifungal Susceptibility Testing of 112 <i>Aspergillus</i> Section <i>Nigri</i> IsolatesB Carrara, R Richards, S Imbert, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
Species Identification and <i>In Vitro</i> Antifungal Susceptibility of Aspergillus terreus Species Complex Clinical Isolates from a French Multicenter StudyS Imbert, A C Normand, S Ranque, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 14, 2011
Pneumocystosis: a network survey in the Paris area 2003-2008D Magne, A Angoulvant, F Botterel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 10, 2014
Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?A Fekkar, E Dannaoui, I Meyer, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Clinical Microbiology|September 12, 2014
PCR-based detection of Toxoplasma gondii DNA in blood and ocular samples for diagnosis of ocular toxoplasmosisC Bourdin, A Busse, E Kouamou, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant <i>Aspergillus</i> Section <i>Fumigati</i> Clinical IsolatesS Dellière, L Verdurme, J Bigot, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2013
Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofunginA Fekkar, I Meyer, J Y Brossas, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 23, 2016
Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and nonneutropenic patientsS Imbert, L Gauthier, I Joly, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 4, 2016
Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemiaS Imbert, L Castain, A Pons, et al.
Journal of Clinical Microbiology|January 21, 2011
Direct genotyping of Toxoplasma gondii in ocular fluid samples from 20 patients with ocular toxoplasmosis: predominance of type II in FranceA Fekkar, D Ajzenberg, B Bodaghi, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2020
Species Distribution and Comparison between EUCAST and Gradient Concentration Strips Methods for Antifungal Susceptibility Testing of 112 <i>Aspergillus</i> Section <i>Nigri</i> IsolatesB Carrara, R Richards, S Imbert, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
Species Identification and <i>In Vitro</i> Antifungal Susceptibility of Aspergillus terreus Species Complex Clinical Isolates from a French Multicenter StudyS Imbert, A C Normand, S Ranque, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 14, 2011
Pneumocystosis: a network survey in the Paris area 2003-2008D Magne, A Angoulvant, F Botterel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 10, 2014
Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?A Fekkar, E Dannaoui, I Meyer, et al.
Pageof 3